Please assess the completion status of the following clinical trial:

Trial Title: Fibrinogen as a Surrogate for Global Haemostasis in Plasma Exchange

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* plasma exchange therapy due to humoral rejection after kidney transplantation~Exclusion Criteria:~* hereditary coagulopathy~* chronic liver disease (Child C)~* therapeutic anticoagulation~* malnutrition (BMI\<17.5)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Humoral rejection, TPE (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).